Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCerillion Regulatory News (CER)

Share Price Information for Cerillion (CER)

Share Price is delayed by 15 minutes
Get Live Data
1,247.50    5.00 (0.40%)
Bid:
1,235.00
Ask:
1,260.00
Spread: 25.00 (2.024%)
Market Cap: £369.26m
CER Live PriceLast checked at - London Stock Exchange

Intraday Cerillion Share Chart

Trading Update

7 Nov 2006 07:02

Celtic Resources Holdings PLC07 November 2006 Embargoed for 7.05am 7 NOVEMBER 2006 Celtic Resources Holdings Plc ("Celtic" or "the Company") TRADING UPDATE AND ADDITIONAL NOTES ON COMPETENT PERSONS REPORT IN EUREKA MINING PLC CIRCULAR Celtic announced today that the boards of Celtic and Eureka Mining PLC("Eureka") have agreed to the terms of a scheme of arrangement under s.425 ofthe Companies Act whereby Celtic will acquire Eureka (the "Scheme"). The detailsof the Scheme are contained in a separate announcement also released today. Thefull text of the associated Scheme circular to Eureka shareholders will be madeavailable on the Company's website, www.celticresources.com, when the Circularhas been posted to Eureka shareholders. The Circular contains a trading updateby Celtic: CURRENT TRADING Monthly gold production at Suzdal has been increasing and the BIOX(R) plant hascompleted an annual cycle which in Kazakhstan covers climatic temperatures from-40degreesC to +40degreesC. Improvements in plant throughput and gold recoveryare continuing. In addition, consideration is being given to expanding thecapacity of the plant to treat concentrates from other sources, including minesin the region which have sulphide ores similar to Suzdal. Since the interim results, published on 12 September 2006, internal forecastshave been reviewed and due to lower mined grades at Suzdal, Celtic now expectsgold production this year to be around 50,000 ozs. Also, due to treatment oflower grade transitional ores at Zherek, production there should be around12,000 ozs of gold this year. At 62,000 ozs, the combined group production willbe 60% higher than last year. At Zherek, Celtic's preliminary technical and economic studies suggest thatsulphide ore could be mined and trucked to Suzdal. Celtic continues to reviewother mining opportunities, primarily in the FSU. COMPETENT PERSONS REPORT SRK has completed a Competent Persons Report on Celtic's assets for the purposesof the Scheme circular, the full text of which is available in the Schemecircular. This included their resources audit that brought all reserve andresource statements into JORC Code as stated in Celtic's 2005 annual report andaccounts. Kevin Foo, Managing Director commented "The Company is pleased that SRK hasconfirmed a 2 million ozs JORC compliant gold resource. The BIOX(R) plant atSuzdal has demonstrated its robustness over the year and we are now consideringan expansion of the plant from capacity 300,000 t/y to 400,000 t/y. This willallow us to process additional Suzdal ore, Zherek ore and other refractory oresand concentrates in the region, thus taking advantage of the fact that ours isthe first successful application of bacterial oxidation in the FSU. " Notes: Terms in this press release shall have the same meaning as the terms inthe Eureka Scheme circular which will be posted to Eureka shareholders today(and will also be made available on Celtic's website). The Mineral ResourceStatement has been prepared by SRK under the JORC code. For further information please contact: Kevin Foo / Kate Dexter Smith Laurence ReadCeltic Resources Holdings Plc Conduit PRTel: + 44 (0)20 7921 8800 Tel: +44(0)20 7429 6666Investors@celticresources.com laurence@conduitpr.com Frank Moxon / Simon EdwardsEvolution Securities LimitedTel: +44 (0) 20 7071 4300 www.celticresources.com This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
30th Nov 20226:29 pmRNSPDMR and PCA shareholding
30th Nov 202211:18 amRNSHolding(s) in Company
28th Nov 20227:00 amRNSFinal Results
23rd Nov 20227:00 amRNSNotice of Results and Investor Presentation
2nd Nov 20225:49 pmRNSHolding(s) in Company
2nd Nov 202212:40 pmRNSHolding(s) in Company
26th Oct 20227:00 amRNSRelease of latest version of flagship product set
24th Oct 20227:00 amRNSTrading Update
6th Oct 20227:00 amRNSAppointment of Joint Broker
25th Aug 20223:48 pmRNSGrant of Options
8th Aug 20223:08 pmRNSHolding(s) in Company
28th Jul 20224:35 pmRNSPrice Monitoring Extension
19th Jul 20227:00 amRNSHolding(s) in Company
6th Jul 20227:00 amRNSMajor Contract Win
13th May 20227:33 amRNSDirector Share Purchase
9th May 20227:00 amRNSInterim Results Presentation
9th May 20227:00 amRNSInterim Results
25th Apr 202210:13 amRNSHolding(s) in Company
19th Apr 20227:00 amRNSH1 2022 Trading Update
6th Apr 20227:00 amRNSCerillion Client MVN-X Reaches Million Subscribers
7th Mar 20227:00 amRNSWins Prestigious Megabuyte Performance Award
2nd Mar 20227:00 amRNSExercise of Options, PDMR Shareholding & TVR
21st Feb 20223:08 pmRNSHolding(s) in Company
21st Feb 20227:00 amRNSShare purchase for Employee Share Option Scheme
15th Feb 20227:00 amRNSRecognised in Two Gartner Market Guide Reports
4th Feb 202211:37 amRNSResult of AGM
31st Jan 20227:00 amRNSConfirmation of Board Appointment
27th Jan 20222:25 pmRNSHolding(s) in Company
24th Jan 20222:05 pmRNSSecond Price Monitoring Extn
24th Jan 20222:00 pmRNSPrice Monitoring Extension
10th Jan 20227:00 amRNSCompletion of Implementation for Norlys
14th Dec 20217:00 amRNSBoard Retirement and Proposed Appointment
26th Nov 20218:37 amRNSPDMR and PCA Shareholding
22nd Nov 20217:00 amRNSFinal Results
16th Nov 20212:42 pmRNSHolding(s) in Company
2nd Nov 20217:00 amRNSRelease of Cerillion 21.2
4th Oct 20217:02 amRNSTrading Update
28th Sep 20217:00 amRNSContracts worth £4.2m with OpenNet
23rd Sep 20216:15 pmRNSHolding(s) in Company
9th Sep 20217:00 amRNSOpening of Bulgaria office
8th Sep 20217:00 amRNSInvestor Presentation
22nd Jul 20214:24 pmRNSHolding(s) in Company
13th Jul 202111:03 amRNSHolding(s) in Company
6th Jul 202111:30 amRNSDirector/PDMR Shareholding
22nd Jun 20217:00 amRNSGrant of Options
18th Jun 20217:00 amRNSEmployee Share Option Scheme
10th Jun 202111:35 amRNSDirector/PDMR shareholding
27th May 20216:03 pmRNSReplacement: Director/PDMR Shareholding
27th May 20213:50 pmRNSDirector/PDMR Shareholding
24th May 20214:59 pmRNSExercise of Options and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.